Friday, July 29, 2011

Lundbeck has issued statements discouraging the use of pentobarbital in executions.

Lundbeck has issued statements discouraging the use of pentobarbital in executions.

“Lundbeck adamantly opposes the distressing misuse of our product in capital punishment,” company CEO Ulf Wiinberg said in a prepared statement Friday. “After much consideration, we have determined that a restricted distribution system is the most meaningful means through which we can restrict the misuse of Nembutal.”
The new distribution proc-ess will deny sales to corrections departments in states that impose death sentences and carry out executions.

No comments: